Bruker (BRKR) Other Non-Current Liabilities (2010 - 2026)
Bruker's (BRKR) quarterly Other Non-Current Liabilities came in at $597.7 million in Q2 2026, down 19.88% on a YoY basis from $746.0 million in Q2 2025, and down 2.0% quarter-over-quarter from $609.9 million in Q1 2026.
Analysis
Bruker (BRKR) Other Non-Current Liabilities (2010 - 2026) Analysis & Trends
Bruker (BRKR) has reported Other Non-Current Liabilities for 17 consecutive years, with $597.7 million the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Other Non-Current Liabilities fell 19.88% year-over-year to $597.7 million; the trailing twelve-month figure through Jun 2026 stood at $597.7 million (down 19.88% YoY), and the FY2025 full-year result was $599.4 million, up 92.73% from the prior year.
- Other Non-Current Liabilities declined to $597.7 million in Q2 2026 per BRKR's latest filing, from $609.9 million in the prior quarter.
- Across five years, Other Non-Current Liabilities topped out at $746.0 million in Q2 2025 and bottomed at $120.8 million in Q4 2022.
- Historically, Other Non-Current Liabilities has averaged $420.1 million across 5 years, with a median of $404.6 million in 2022.
- The sharpest annual moves came in 2024 and 2025: Other Non-Current Liabilities sank 57.86% in 2024, then soared 318.4% in 2025.
- Over 5 years, Other Non-Current Liabilities stood at $120.8 million in 2022, then jumped by 98.84% to $240.2 million in 2023, then rose by 29.48% to $311.0 million in 2024, then jumped by 92.73% to $599.4 million in 2025, then declined by 0.28% to $597.7 million in 2026.
- According to Business Quant data, Other Non-Current Liabilities over the past three periods registered $597.7 million, $609.9 million, and $599.4 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 225.48 Bn | 221.41 Bn | 8.34 Bn |
| 2 | Danaher | 144.42 Bn | 140.08 Bn | 3.61 Bn |
| 3 | Agilent Technologies | 40.86 Bn | 39.11 Bn | 1.04 Bn |
| 4 | Illumina | 30.97 Bn | 29.80 Bn | 770.00 Mn |
| 5 | Revvity | 13.85 Bn | 12.83 Bn | 416.87 Mn |
| 6 | Bio-Techne | 11.27 Bn | 11.01 Bn | 211.39 Mn |
| 7 | Bio-Rad Laboratories | 10.11 Bn | 8.49 Bn | 345.80 Mn |
| 8 | Repligen | 9.33 Bn | 8.31 Bn | 110.04 Mn |
| 9 | 10x Genomics | 8.77 Bn | 8.21 Bn | 112.50 Mn |
| 10 | Bruker | 8.30 Bn | 8.09 Bn | 416.00 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 597.70 Mn |
| Mar 31, 2026 | 609.90 Mn |
| Dec 31, 2025 | 599.40 Mn |
| Sep 30, 2025 | 690.20 Mn |
| Jun 30, 2025 | 746.00 Mn |
| Mar 31, 2025 | 660.90 Mn |
| Dec 31, 2024 | 311.00 Mn |
| Sep 30, 2024 | 206.30 Mn |
| Jun 30, 2024 | 178.30 Mn |
| Mar 31, 2024 | 166.70 Mn |
| Dec 31, 2023 | 240.20 Mn |
| Sep 30, 2023 | 404.50 Mn |
| Jun 30, 2023 | 421.00 Mn |
| Mar 31, 2023 | 395.60 Mn |
| Dec 31, 2022 | 120.80 Mn |
| Sep 30, 2022 | 381.80 Mn |
| Jun 30, 2022 | 404.70 Mn |
| Mar 31, 2022 | 426.70 Mn |
| Dec 31, 2021 | 162.20 Mn |
| Sep 30, 2021 | 399.10 Mn |